Professor Ewan Birney FRS is Deputy Director General of EMBL, and also a joint Director of EMBL-EBI.
As Deputy Director General he supports the Director General in executing her overall vision across EMBL. He has specific responsibility to increase EMBL’s engagement with its Member States and to expand its global influence.
As Director of EMBL-EBI he provides oversight and leadership with Rolf Apweiler for the direction of EMBL-EBI, working closely with Associate Directors Paul Flicek, Jo McEntyre and the Head of Research at EMBL-EBI, Nick Goldman.
Ewan completed his PhD at the Wellcome Sanger Institute with Richard Durbin. In 2000, he became Head of Nucleotide data at EMBL-EBI and in 2012 he took on the role of Associate Director at the institute. He became Director of EMBL-EBI in 2015.
Ewan is a non-executive Director of Genomics England, and a consultant and advisor to a number of companies, including Oxford Nanopore Technologies, Dovetail Genomics and GSK. Ewan was elected an EMBO member in 2012, a Fellow of the Royal Society in 2014 and a Fellow of the Academy of Medical Sciences in 2015. In 2019, Ewan became a Board Member of the Biotechnology and Biological Sciences Research Council (BBSRC).
Ewan continues to direct a small research group focused on outbred genetics in human and Japanese rice paddy fish.